Literature DB >> 6165322

Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells.

A K Field, E M Scattergood, C J Hopke, A A Tytell, M R Hilleman.   

Abstract

Growth and interferon production by human lymphoblastoid cells (Namalva) have been achieved by using medium with a complete substitution of human albumin for fetal bovine serum. Medium containing 0.3% human albumin supported exponential cell growth (minimum doubling time, 20 h) in Bilthoven 10-liter fermentors. Interferon induction with Sendai virus resulted in interferon yields of 0.5 x 10(4) to 1.0 x 10(4) interferon units per 10(6) Namalva cells per ml in RPMI 1640 medium containing 0.15 to 0.3% human albumin. Both cell growth and interferon production in medium containing human albumin were comparable to growth and interferon production in the same medium containing 10 and 5% fetal bovine serum, respectively.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6165322      PMCID: PMC352991          DOI: 10.1128/AAC.18.6.930

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

Review 1.  Clinical trials with exogenous interferon: summary of a meeting.

Authors:  J K Dunnick; G J Galasso
Journal:  J Infect Dis       Date:  1979-01       Impact factor: 5.226

2.  Production of human lymphoblastoid interferon.

Authors:  H Strander; K E Mogensen; K Cantell
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

3.  Production of human lymphoblastoid interferon by Namalva cells.

Authors:  K C Zoon; C E Buckler; P J Bridgen; D Gurari-Rotman
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

4.  Preparation of human leukocyte interferon for clinical use.

Authors:  K Cantell; S Hirvonen
Journal:  Tex Rep Biol Med       Date:  1977

5.  Large-scale production and concentration of human lymphoid interferon.

Authors:  F Klein; R T Ricketts; W I Jones; I A DeArmon; M J Temple; K C Zoon; P J Bridgen
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

Review 6.  Vaccine production as a unit process.

Authors:  P van Hemert
Journal:  Prog Ind Microbiol       Date:  1974

7.  Characteristics of human lymphoblastoid (Namalva) interferon.

Authors:  E A Havell; Y K Yip; J Vilcek
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

8.  Production of human lymphoblastoid interferon by Namalwa cells cultured in serum-free media.

Authors:  K C Zoon; P J Bridgen; M E Smith
Journal:  J Gen Virol       Date:  1979-07       Impact factor: 3.891

Review 9.  Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man.

Authors:  H Strander
Journal:  Tex Rep Biol Med       Date:  1977
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.